Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study

BACKGROUND: There is continued uncertainty regarding the risks of hepato‐pancreato‐biliary cancers in patients with inflammatory bowel disease (IBD) with or without concomitant primary sclerosing cholangitis (PSC). OBJECTIVE: To give updated estimates on risk of hepato‐pancreato‐biliary cancers in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jingru, Refsum, Erle, Helsingen, Lise M., Folseraas, Trine, Ploner, Alexander, Wieszczy, Paulina, Barua, Ishita, Jodal, Henriette C., Melum, Espen, Løberg, Magnus, Blom, Johannes, Bretthauer, Michael, Adami, Hans‐Olov, Kalager, Mette, Ye, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911542/
https://www.ncbi.nlm.nih.gov/pubmed/35107865
http://dx.doi.org/10.1002/ueg2.12204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911542/
https://www.ncbi.nlm.nih.gov/pubmed/35107865
http://dx.doi.org/10.1002/ueg2.12204

Ejemplares similares